Clinical Trials in Ohio

Showing 1381-1400 of 17,983 trials

Expanded Access to Bezuclastinib for Patients With NonAdvanced Systemic Mastocytosis or Advanced Systemic Mastocytosis

NCT06915766

The purpose of this expanded access program (EAP) protocol is to provide investigational bezuclastinib to patients with a diagnosis of nonadvanced systemic mastocytosis (NonAdvSM) or advanced systemic mastocytosis (AdvSM) who have received and failed or been intolerant to at least one standard approved therapy and/or have no comparable or satisfactory alternative therapy options.

Systemic Mastocytoses, IndolentSystemic Mastocytoses, Aggressive

Cogent Biosciences, Inc.

La Jolla, California, United States • La Jolla, California, United States • Los Angeles, California, United States +15 more locations

RECRUITINGPhase 332 miles

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

NCT07177352

This study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease studies.

Alzheimers Disease

Hoffmann-La Roche13,000 participantsStarted Jul 2025

Phoenix, Arizona, United States • Sun City, Arizona, United States • Imperial, California, United States +204 more locations

Expanded Access to Bezuclastinib for Patients With NonAdvanced Systemic Mastocytosis or Advanced Systemic Mastocytosis

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

Find Trials by Condition in Ohio

Registry 17-009: Multi-Institutional Study Examining Patients With HCC Undergoing Liver Transplantation

A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis

A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications

Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65).

A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts

Study of V117957 in Interstitial Cystitis/Bladder Pain Syndrome

AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2

HOPE in Action Trial of HIV+ Deceased Donor Liver Transplants for HIV+ Recipients

A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)

Clinical and Genetic Studies of X-Linked Juvenile Retinoschisis

A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)

Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON)

ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03)

A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy

NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors

Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

A Study in People With Idiopathic Pulmonary Fibrosis to Test Whether Pirfenidone Influences the Amount of BI 1015550 in the Blood